JPRN-UMIN000012549招募中未知
Combination Treatment of Intravitreal Ranibizumab, focal/Grid Laser and panretinal photocoagulation in patients with diabetic macular edema - Combination treatment of intravitreal Ranibizumab and photocoagulation in patients with diabetic macula edema
Shinshu university school of medicine Department of Ophthalmology0 个研究点目标入组 40 人开始时间: 2014年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)concomitant conditions in the study eye that could prevent the improvement in VA on the study 2)active intraocular inflammation or infection in either eye 3)uncontrolled glaucoma in either eye 4)treatment with antiangiogenic drugs in the study eye within 3 months before randomization 5)history of stroke and systolic blood pressure>160mmHg or diastolic BP>100mmHg,untreated hypertension, or change in antihypertensive treatment within 3 months preceding baseline.
研究者
相似试验
进行中（未招募）
1 期
Injections into the eye (drug Lucentis) in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macula associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersEUCTR2013-000031-27-GBMoorfields Eye Hospital80
进行中（未招募）
1 期
Intravitreal ranibizumab in patients with retinal pigment epithelial detachments secondary to AMDEUCTR2008-004675-22-DEniversity of Bonn20
尚未招募
4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese PatientsExudative Age-Related Macular DegenerationJPRN-UMIN000027799Akita University Department of Ophthalmology50
已完成
4 期
A multicentre,open-label,prospective,observational study to evaluate effectiveness and safety of repeated intravitreal injections of Lucentis® in patients with wet age-related macular degeneration over a 12-month observational period in a real-world settingCTRI/2013/08/003933ovartis India Limited3,000
已完成
不适用
Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuityneovascular age-related macular degenerationJPRN-UMIN000015073Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences40